Table 2.
Absorbed organs dose per administered activity (± SD) for 64CuCl2
| Organ | Absorbed organ dose per administered activity (mGy/MBq) |
|---|---|
| Adrenals | 2.54E-2 (± 6.60E-3) |
| Brain | 1.04E-2 (± 3.95E-3) |
| Breasts | 1.22E-2 (± 4.07E-3) |
| Gallbladder wall | 7.82E-2 (± 2.99E-2) |
| Lower larger intestine wall | 1.25E-2 (± 4.76E-3) |
| Upper large intestine wall | 1.78E-2 (± 5.31E-3) |
| Small intestine | 1.62E-2 (± 5.42E-3) |
| Stomach wall | 1.70E-2 (± 5.48E-3) |
| Heart wall | 1.80E-2 (± 5.30E-3) |
| Kidneys | 1.39E-1 (± 3.72E-2) |
| Liver | 2.71E-1 (± 3.37E-2) |
| Lungs | 1.64E-2 (± 4.88E-3) |
| Muscle | 1.34E-2 (± 4.51E-3) |
| Pancreas | 8.39E-2 (± 4.03E-2) |
| Red marrow | 2.26E-2 (± 9.04E-3) |
| Osteogenic cells | 3.00E-2 (± 1.16E-2) |
| Skin | 1.09E-2 (± 3.84E-3) |
| Spleen | 3.63E-2 (± 1.37E-2) |
| Testes | 1.10E-2 (± 4.14E-3) |
| Thymus | 1.31E-2 (± 4.53E-3) |
| Thyroid | 1.16E-2 (± 4.31E-3) |
| Urinary bladder wall | 1.27E-2 (± 4.69E-3) |
| Salivary glands | 3.70E-2 (± 3.70E-2) |
| Total body | 2.09E-2 (± 5.61E-3) |
| Effective dose ICRP 60 (mSv/MBq) | 3.10E-2 (± 8.07E-3) |
| Effective dose ICRP 103 (mSv/MBq) | 2.91E-2 (± 7.83E-3) |